Original language | Undefined/Unknown |
---|---|
Pages (from-to) | 116-128 |
Number of pages | 13 |
Journal | Journal of the National Cancer Institute |
Volume | 94 |
Issue number | 2 |
Publication status | Published - 2002 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Pooled analysis of prognostic impact of urokinase-type plasminogen acticvator and its inhibitor PAI-1 in 8377 breast cancer patients. / Look, Maxime; Putten, Wim; Duffy, MJ; Harbeck, N; Christensen, IJ; Thomssen, C; Kates, R; Spyratos, F; Fernö, M; Eppenberger-Castori, S; Sweep, CGJ; Ulm, K; Peyrat, J-P; Martin, PM; Magdelenat, H; Brüner, N; Duggan, C; Lisboa, BW; Bendahl, P-O; Quillien, V; Daver, A; Ricolleau, G; Meijer - Gelder, M; Manders, P; Fiets, WE; Blankenstein, MA; Brot, P; Daxenbichler, G; Windbichler, G; Cufer, T; Borstnar, S; Kueng, W; Beex, LVAM; Klijn, Jan; O' Higgins, N; Eppenberger, U; Jäicke, F; Schmitt, M; Foekens, John.
In: Journal of the National Cancer Institute, Vol. 94, No. 2, 2002, p. 116-128.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Pooled analysis of prognostic impact of urokinase-type plasminogen acticvator and its inhibitor PAI-1 in 8377 breast cancer patients.
AU - Look, Maxime
AU - Putten, Wim
AU - Duffy, MJ
AU - Harbeck, N
AU - Christensen, IJ
AU - Thomssen, C
AU - Kates, R
AU - Spyratos, F
AU - Fernö, M
AU - Eppenberger-Castori, S
AU - Sweep, CGJ
AU - Ulm, K
AU - Peyrat, J-P
AU - Martin, PM
AU - Magdelenat, H
AU - Brüner, N
AU - Duggan, C
AU - Lisboa, BW
AU - Bendahl, P-O
AU - Quillien, V
AU - Daver, A
AU - Ricolleau, G
AU - Meijer - Gelder, M
AU - Manders, P
AU - Fiets, WE
AU - Blankenstein, MA
AU - Brot, P
AU - Daxenbichler, G
AU - Windbichler, G
AU - Cufer, T
AU - Borstnar, S
AU - Kueng, W
AU - Beex, LVAM
AU - Klijn, Jan
AU - O' Higgins, N
AU - Eppenberger, U
AU - Jäicke, F
AU - Schmitt, M
AU - Foekens, John
PY - 2002
Y1 - 2002
M3 - Article
VL - 94
SP - 116
EP - 128
JO - Journal of the National Cancer Institute
JF - Journal of the National Cancer Institute
SN - 0027-8874
IS - 2
ER -